The House panel responsible for federal appropriations legislation passed a bill last week that would cut funding for the Health [...] …
Category: Regulatory
The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...] …